These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1382440)

  • 1. Mast cell degranulating (MCD) peptide analogs with reduced ring structure.
    Buku A; Reibman J; Pistelli A; Blandina P; Gazis D
    J Protein Chem; 1992 Jun; 11(3):275-80. PubMed ID: 1382440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivities and secondary structure of mast cell degranulating (MCD) peptide analogs.
    Buku A; Maulik G; Hook WA
    Peptides; 1998; 19(1):1-5. PubMed ID: 9437730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the structural requirements for mast cell degranulating (MCD) peptide-mediated histamine release.
    Buku A; Price JA
    Peptides; 2001 Dec; 22(12):1987-91. PubMed ID: 11786181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular dichroism (CD) studies on biological activity of mast cell degranulating (MCD) peptide analogs.
    Buku A; Mirza U; Polewski K
    Int J Pept Protein Res; 1994 Nov; 44(5):410-3. PubMed ID: 7534751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid phase synthesis and biological activity of mast cell degranulating (MCD) peptide: a component of bee venom.
    Buku A; Blandina P; Birr C; Gazis D
    Int J Pept Protein Res; 1989 Feb; 33(2):86-93. PubMed ID: 2468626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial alanine scan of mast cell degranulating peptide (MCD): importance of the histidine- and arginine residues.
    Buku A; Mendlowitz M; Condie BA; Price JA
    J Pept Sci; 2004 Jun; 10(6):313-7. PubMed ID: 15214434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell degranulating (MCD) peptide: a prototypic peptide in allergy and inflammation.
    Buku A
    Peptides; 1999; 20(3):415-20. PubMed ID: 10447103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective mast cell degranulating peptide inhibitors of the IgE/Fc epsilonRI receptor interaction.
    Buku A; Keselman I; Lupyan D; Mezei M; Price JA
    Chem Biol Drug Des; 2008 Aug; 72(2):133-9. PubMed ID: 18624811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine-releasing activity and binding to the FcepsilonRI alpha human mast cell receptor subunit of mast cell degranulating peptide analogues with alanine substitutions.
    Buku A; Mendlowitz M; Condie BA; Price JA
    J Med Chem; 2003 Jul; 46(14):3008-12. PubMed ID: 12825939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid sequence of bumblebee MCD peptide: a new mast cell degranulating peptide from the venom of the bumblebee Megabombus pennsylvanicus.
    Argiolas A; Herring P; Pisano JJ
    Peptides; 1985; 6 Suppl 3():431-6. PubMed ID: 2421265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding.
    Buku A; Price JA; Mendlowitz M; Masur S
    Peptides; 2001 Dec; 22(12):1993-8. PubMed ID: 11786182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the interaction of mast cell-degranulating peptide with pertussis toxin-sensitive G proteins in mast cells.
    Mousli M; Bronner C; Bueb JL; Landry Y
    Eur J Pharmacol; 1991 Jul; 207(3):249-55. PubMed ID: 1716580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell degranulating peptide: a multi-functional neurotoxin.
    Ziai MR; Russek S; Wang HC; Beer B; Blume AJ
    J Pharm Pharmacol; 1990 Jul; 42(7):457-61. PubMed ID: 1703229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors.
    Buku A; Condie BA; Price JA; Mezei M
    J Pept Res; 2005 Sep; 66(3):132-7. PubMed ID: 16083440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterization of high-affinity binding sites in rat brain for the mast cell-degranulating peptide from bee venom using the purified monoiodinated peptide.
    Taylor JW; Bidard JN; Lazdunski M
    J Biol Chem; 1984 Nov; 259(22):13957-67. PubMed ID: 6501283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histamine-liberating action of MCD-peptide from bee venom].
    Gushchin IS; Miroshnikov AI; Martynov VI
    Biull Eksp Biol Med; 1977 Jul; 84(7):78-80. PubMed ID: 70248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic peptides in bee venom, VI. Structure-activity studies on the anti-inflammatory effects of derivatives and fragments of the MCD-peptide (author's transl)].
    Martin W; Hartter P
    Hoppe Seylers Z Physiol Chem; 1980 Apr; 361(4):525-35. PubMed ID: 7380393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells.
    Jasani B; Kreil G; Mackler BF; Stanworth DR
    Biochem J; 1979 Sep; 181(3):623-32. PubMed ID: 92986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and structure analysis of bee venom mast cell degranulating peptide.
    Dotimas EM; Hamid KR; Hider RC; Ragnarsson U
    Biochim Biophys Acta; 1987 Feb; 911(3):285-93. PubMed ID: 3814606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell and neutrophil interactions: a role for superoxide anion and histamine.
    Fantozzi R; Brunelleschi S; Giuliattini L; Blandina P; Masini E; Cavallo G; Mannaioni PF
    Agents Actions; 1985 Apr; 16(3-4):260-4. PubMed ID: 2409774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.